Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData. BMS had the ...

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major ...

Some of the most exciting new drugs are being discovered by mid-sized pharma and biotech ... analysed a group of 35 mid-cap companies, most of which are based in the US, but does include European ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Many major Indian pharmaceutical companies, including Dr Reddy's, Sun Pharma, and Aurobindo, derive 40-45% of their revenues from the US market, making them particularly vulnerable to any adverse ...

Detailed price information for Bridgebio Pharma Inc (BBIO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX) Year-to-date gain: 68.44 percent Market cap: US$57.41 million Share price: US$4.11 Cumberland Pharmaceuticals is a Tennessee-based biopharma which ...